上海市免疫治疗创新研究院（以下简称“研究院”）经上海市人民政府批准设立，由上海市人民政府和欧洲杯竞猜平台共同建设。研究院面向“健康中国”这一国家战略，由国际著名免疫学家、中国科学院院士董晨教授领衔，依托欧洲杯竞猜平台及其附属仁济医院进行系统性建设，整合欧洲杯竞猜平台和仁济医院在免疫学基础研究和临床免疫的学科优势及丰富的临床资源优势，深度融入张江、临港国家实验室整体发展布局，以免疫学相关基础和应用基础研究为切入点，聚焦肿瘤免疫治疗、慢性炎症疾病与移植免疫、传染性疾病与疫苗三大重点研发方向和应用领域，努力建设成为具有全球影响力的免疫创新策源地、免疫学领域的高端和关键人才的引育基地、国际一流的免疫学基础创新到产业应用的转化基地。
研究院现有空间位于欧洲杯竞猜平台重庆南路园区1号楼6、7两层（1000㎡）和仁济医院东院区科研楼14楼（1500㎡）；另有仁济医院南院区8000㎡实用面积的科研空间正在装修中，预计于2022年投入使用。
上海市免疫治疗创新研究院诚邀国内外青年英才加盟，包括相关高层次人才计划申报者、青年学科骨干（PI）、专职科研人员及优秀博士后研究人员。我们将提供优厚的薪酬待遇、良好的成长空间及全面的生活保障。
Shanghai Immune Therapy Institute (SITI), approved by Shanghai Municipal People’s Government, is jointly established and run by Shanghai Jiao Tong University School of Medicine (SJTUSM) and its affiliated Renji Hospital under the leadership of Dr. DONG Chen, world famous immunologist and Academician of the Chinese Academy of Sciences. SITI will gather advantages of both SJTUSM and Renji Hospital in basic and clinical advantages in immunology and integrate itself into the overall development outlook of State key laboratories in the Zhangjiang National Innovation Demonstration Zone and the Lingang free trade area in Pudong New District. Tumor immunotherapy, chronic inflammatory diseases and transplantation immunology, and infectious diseases and vaccines are the three major R&D and application areas for our institute.
SITI will make its share of contribution to the high-quality development of the biomedicine industry in Shanghai and the national strategy of Healthy China. Phased goals for the institute include being built into a full-chain scientific research platform regarding immune-related diseases by 2025. It is also expected to become an R&D center with a group of internationally influential professionals in this field and with global influence.
By 2035, SITI is set to have an internationally leading position in the research fields of new drug targets, new mechanisms, antibody drug development, immunotherapy and other major immune-related diseases. It is expected to become a core element in Shanghai's world-class biomedical industry cluster, which is under construction, as well as in the city's independent innovation efforts.
Join us:
SITI welcomes young talents from both home and abroad to join us on this exciting journey of scientific exploration to improve human health. Posts available include high-level talent program applicants, PI, full-time researchers and post-doc research fellows. We will provide competitive salaries and remuneration, promising career development opportunities and strong support for relocation.
